Lv32
388 积分 2025-11-21 加入
Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
1天前
待确认
Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome
14天前
已完结
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
14天前
已完结
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
15天前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
15天前
已完结
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
15天前
已完结
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
2个月前
已完结
Hallmarks of cancer—Then and now, and beyond
7个月前
已完结
CD8+ T cell exhaustion and cancer immunotherapy
9个月前
已完结
Dissecting the mechanisms of immune checkpoint therapy
9个月前
已完结
皖公网安备34019202002308
